News

From our CEO

25 July 2023

Rohan Greenland The May 50K

You could be forgiven if you missed World Brain Day on July 22.

It certainly deserves much more attention, especially by our politicians. An initiative of the World Federation of Neurology, it helps promote the concept of brain health.

Here in Australia, we know that around one-in-six people have a neurological or neuromuscular condition.

Despite these very significant numbers, we don’t have a national neurological action plan, nor do we know what the Australian Government is doing to implement the 2022 Global Action Plan for Neurological Disorders.

The need for action is clear.

The Neurological Alliance Australia, which we currently Chair, and MS Australia are calling for:

  • A national neurological research mission within the Medical Research Future Fund (neurological research is under-funded)
  • A national minimum data set for neurological conditions (unbelievably, there is no national data set)
  • A neurological advisory group to improve access and equity to the NDIS
  • Better investment in public health, including a focus on brain health, and
  • An urgent boost in the number of MS nurses.

Most of the major disease groups have dedicated action plans, research initiatives and data collections. But neurological conditions are being left behind, even though more than four million Australians are living with one or more of these disorders.

Time for change. Time for action.

Related News

MS News

Women and MS: one of the disease’s biggest mysteries

9 September 2026

Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.

MS News

From our CEO: MS medication ‘rapid review’: Make your voice heard!

27 August 2026

Ahead of an upcoming PBAC stakeholder meeting on MS medicines, CEO Rohan Greenland outlines MS Australia’s key messages, including the importance of treatment choice and continued PBS access.

MS News

Have Your Say: PBAC review of MS treatments open for public consultation

27 August 2026

A public consultation is now open as part of a rapid review of PBS-listed medicines for relapsing-remitting MS. The MS community has an important opportunity to share their experiences and help ensure the lived experience of Australians with MS remains central to future PBS decisions.

Read More
WHO three MS medicines added to EML

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

From our CEO